Newsroom

Sorted by: Latest
-

Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib) for the Treatment of Active Psoriatic Arthritis in Adults

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib) for the Treatment of Active Psoriatic Arthritis in Adults...
-

Samson Rock Capital LLP UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: SAMSON ROCK CAPITAL LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named....
-

Dollar General Literacy Foundation Celebrates Another One-Day Grant Milestone

GOODLETTSVILLE, Tenn.--(BUSINESS WIRE)--Dollar General Literacy Foundation Celebrates Another One-Day Grant Milestone...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Opportunities UCITS ETF 07.05.2026 FPX. IE00BYTH6238 175,002.00 USD 11,999,140.18 68.566  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 07.05.2026 GINC LN IE00BD842Y21 899,606.00 USD 57,801,245.18 64.252  ...
-

再生醫學領域的開創性成就：BEES-HAUS細胞療法——藉由旁分泌效應與細胞植入，共同治癒尿道狹窄。其簡化版本BHES-HAUS的研究成果將於2026年美國泌尿科協會年會（AUA 2026）上發表

東京--(BUSINESS WIRE)--(美國商業資訊)-- 印日醫師科學家團隊報告了一項突破性的科學發現，揭示了BEES-HAUS細胞療法在尿道狹窄中成功促進傷口癒合的機制。這項再生醫學領域的重大成就，展現了臨床安全性與療效，是同類療法中的首創。該療法採用混合方式，將兩組自體頰黏膜上皮細胞 （一組以2D培養，另一組在Festigel支架中以3D培養）混合使用來治療尿道狹窄；2D培養細胞所產生的IGF-1之旁分泌效應，以及覆蓋於尿道切開傷口上的3D-Festigel培養細胞之植入作用，共同修復了尿路上皮缺損。該研究成果已發表於《Frontiers in Urology》研究人員認為，這項成就雖不算宏大，但在體外組織工程與透過體內癒合帶來臨床益處、恢復尿路上皮完整性方面，均為全球首創；其潛力在於能為排尿困難的患者帶來無狹窄復發、良好生活品質的未來，因此是一大躍進。 已有文獻報導利用組織工程技術在實驗室中創造器官（如尿道）的研究。然而，針對男性尿道狹窄提供長期無復發的解決方案仍然是一項挑戰。氣球擴張或DVIU尿道切開術會使尿路上皮下組織暴露於尿液，引發發炎反應，導致海綿體纖維化及狹窄復發...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 07.05.2026 FGBL.LN IE00BYTH6121 1,020,847.00 USD 98,521,129.27 96.509  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 07.05.2026 FKUD IE00BD9N0445 118,031.00 GBP 3,498,680.85 29.642  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 07.05.2026 FKU IE00B8X9NZ57 209,100.00 GBP 8,864,064.90 42.392  ...
-

Leveraging the Legacy of the 2025 Osaka Expo — SkyDrive and Partners Launch Japan’s First Consortium for Vertiport Operations —

TOYOTA, Japan--(BUSINESS WIRE)--SkyDrive Inc. (“SkyDrive”), a leading Japanese developer of electric vertical takeoff and landing (eVTOL) (*1) aircraft, is proud to announce the formation of Japan’s first consortium for the commercial operation and joint usage of an eVTOL vertiport. The new consortium, which brings together the Osaka prefectural government, Osaka municipal government, Osaka Metro Co., Ltd., Soracle and Marubeni Corporation will support the commercialization of Osakako Vertiport...